Invesco
FBRX icon

Invesco’s Forte Biosciences FBRX Stock Holding History

Invesco’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$261K Buy
+12,279
New +$291K ﹤0.01% 3487
2021
Q3 		– Sell
-7,488
Closed -$6.29M – 4030
2021
Q2 		$6.29M Sell
7,488
-4,623
-38% -$4.17M ﹤0.01% 2328
2021
Q1 		$10.4M Buy
12,111
+49
+0.4% +$40.1K ﹤0.01% 1924
2020
Q4 		$11M Buy
12,062
+11,238
+1,364% +$10.6M ﹤0.01% 1754
2020
Q3 		$999K Buy
+824
New +$546K ﹤0.01% 2825

Other funds holding FBRX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Invesco's FBRX Position: Q2 2026 in Review

Invesco opened a new position in Forte Biosciences (FBRX) in Q2 2026: 12,279 shares worth $261K. The stake represents ﹤0.01% of the portfolio and ranks #3487 among its holdings. This is a return to the name: Invesco previously reported a position in FBRX as recently as Q2 2021.

Invesco first reported a position in FBRX in Q3 2020 and has held it in 5 quarters since. The position peaked at $11M in Q4 2020. 86 funds tracked by Wall St. Rank hold FBRX as of Q2 2026.

  • Invesco held 12,279 shares of Forte Biosciences worth $261K as of Q2 2026.
  • Forte Biosciences was a new Invesco position in Q2 2026.
  • Forte Biosciences made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3487 holding.
  • Invesco first reported a position in Forte Biosciences in Q3 2020 and has held it in 5 quarters since.
  • Invesco's Forte Biosciences position peaked at $11M in Q4 2020.
  • 86 funds tracked by Wall St. Rank held Forte Biosciences as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.